Qiyu Zhu, Jinge Zhao, Pengfei Shen, Ming Zhang, Qian Wang. "Tislelizumab in combination with abiraterone/enzalutamide for metastatic castration-resistant prostate cancer with intraductal adenocarcinoma of the prostate after progression on prior androgen receptor pathway inhibitor.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.tps299